NCT06777563 EMA and mHealth in Preventing Postpartum Depression
| NCT ID | NCT06777563 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The University of Hong Kong |
| Condition | Postpartum Depression (PPD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-08-25 |
| Primary Completion | 2025-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-08-25 with a primary completion date of 2025-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This proposed study aims to develop and examine the feasibility, acceptability, and preliminary effectiveness of a proactive intervention model that combines brief psychological counselling, Ecological Momentary Assessment (EMA), mHealth-based psychological support, and CBT-guided telephone counselling to prevent postpartum depression (PPD).
Eligibility Criteria
Inclusion Criteria: 1. Pregnant women who are in their 20 to 28 weeks of gestation, 2. Receiving regular antenatal care service in Hong Kong, 3. Had a total score ≥7 in EPDS-10 (suggesting potential distress symptoms), 4. Able to read and understand Chinese and use an instant messaging app weekly Exclusion Criteria: 1\) Pregnant women who are undergoing psychiatric/psychological treatment.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06777563 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Postpartum Depression (PPD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06777563 currently recruiting?
Yes, NCT06777563 is actively recruiting participants. Contact the research team at lubabezz@connect.hku.hk for enrollment information.
Where is the NCT06777563 trial being conducted?
This trial is being conducted at Hong Kong, Hong Kong, Hong Kong, Hong Kong.
Who is sponsoring the NCT06777563 clinical trial?
NCT06777563 is sponsored by The University of Hong Kong. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.